1. Comparative Bioavailability of Amphetamine Extended-Release Oral Suspension and Extended-Release Mixed Amphetamine Salts. (April 2021) Authors: Pardo, Antonio; Bouhajib, Mohammed; Rafla, Eman; King, Thomas R.; Kando, Judith C. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of the Amphetamine Extended-Release Tablet in Adults with Attention-Deficit/Hyperactivity Disorder. (April 2022) Authors: Cutler, Andrew J.; Childress, Ann C.; Pardo, Antonio; Rafla, Eman; Duhoux, Stephanie; Kando, Judith C.; Dansie, Lori Journal: CNS spectrums Issue: Volume 27:Number 2(2022) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in 6–12-Year-Old Children with ADHD. (April 2021) Authors: Pardo, Antonio; Childress, Ann C.; King, Thomas R.; Rafla, Eman; Kando, Judith C. Journal: CNS spectrums Issue: Volume 26:Number 2(2021) Page Start: 163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. (22nd December 2020) Authors: Pardo, Antonio; Kando, Judith C.; King, Thomas R.; Rafla, Eman; Herman, Barry K. Journal: CNS spectrums Issue: Volume 25:Number 6(2020) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗